A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy Participants

NCT02016066 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study terminated due to business decision

Conditions

Healthy

Interventions

DRUG: CR6261
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.